259 related articles for article (PubMed ID: 27618577)
1. Berberine-loaded Janus nanocarriers for magnetic field-enhanced therapy against hepatocellular carcinoma.
Wang Z; Wang YS; Chang ZM; Li L; Zhang Y; Lu MM; Zheng X; Li M; Shao D; Li J; Chen L; Dong WF
Chem Biol Drug Des; 2017 Mar; 89(3):464-469. PubMed ID: 27618577
[TBL] [Abstract][Full Text] [Related]
2. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
3. Facile Synthesis of Core-shell Magnetic Mesoporous Silica Nanoparticles for pH-sensitive Anticancer Drug Delivery.
Shao D; Wang Z; Dong WF; Zhang X; Zheng X; Xiao XA; Wang YS; Zhao X; Zhang M; Li J; Huo QS; Chen L
Chem Biol Drug Des; 2015 Dec; 86(6):1548-53. PubMed ID: 26216620
[TBL] [Abstract][Full Text] [Related]
4. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
5. Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs.
Feng Y; Li NX; Yin HL; Chen TY; Yang Q; Wu M
Mol Pharm; 2019 Jan; 16(1):422-436. PubMed ID: 30525641
[TBL] [Abstract][Full Text] [Related]
6. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier.
Lv Y; Li J; Chen H; Bai Y; Zhang L
Int J Nanomedicine; 2017; 12():4361-4370. PubMed ID: 28652738
[TBL] [Abstract][Full Text] [Related]
8. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
9. Berberine-loaded Janus gold mesoporous silica nanocarriers for chemo/radio/photothermal therapy of liver cancer and radiation-induced injury inhibition.
Li XD; Wang Z; Wang XR; Shao D; Zhang X; Li L; Ge MF; Chang ZM; Dong WF
Int J Nanomedicine; 2019; 14():3967-3982. PubMed ID: 31239666
[No Abstract] [Full Text] [Related]
10. Magnetic targeting and pH-microwave dual responsive Janus mesoporous silica nanoparticles for drug encapsulation and delivery.
He Y; Wang C; Wu Q; Zhang G
Nanotechnology; 2024 May; 35(31):. PubMed ID: 38657569
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Zhao R; Li T; Zheng G; Jiang K; Fan L; Shao J
Biomaterials; 2017 Oct; 143():1-16. PubMed ID: 28755539
[TBL] [Abstract][Full Text] [Related]
12. Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies.
Kumar V; Bhatt PC; Rahman M; Kaithwas G; Choudhry H; Al-Abbasi FA; Anwar F; Verma A
Int J Nanomedicine; 2017; 12():6747-6758. PubMed ID: 28932118
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
Wu L; Wu M; Zeng Y; Zhang D; Zheng A; Liu X; Liu J
Nanotechnology; 2015 Jan; 26(2):025102. PubMed ID: 25517859
[TBL] [Abstract][Full Text] [Related]
14. Dual-pH/Magnetic-Field-Controlled Drug Delivery Systems Based on Fe
Hu X; Wang Y; Zhang L; Xu M; Zhang J; Dong W
ChemMedChem; 2017 Oct; 12(19):1600-1609. PubMed ID: 28857472
[TBL] [Abstract][Full Text] [Related]
15. Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy.
Li Y; Miao Y; Chen M; Chen X; Li F; Zhang X; Gan Y
Theranostics; 2020; 10(8):3722-3736. PubMed ID: 32206118
[No Abstract] [Full Text] [Related]
16. Novel Chinese Angelica Polysaccharide Biomimetic Nanomedicine to Curcumin Delivery for Hepatocellular Carcinoma Treatment and Immunomodulatory Effect.
Guo C; Hou X; Liu Y; Zhang Y; Xu H; Zhao F; Chen D
Phytomedicine; 2021 Jan; 80():153356. PubMed ID: 33039729
[TBL] [Abstract][Full Text] [Related]
17. Shape-controlled magnetic mesoporous silica nanoparticles for magnetically-mediated suicide gene therapy of hepatocellular carcinoma.
Wang Z; Chang Z; Lu M; Shao D; Yue J; Yang D; Zheng X; Li M; He K; Zhang M; Chen L; Dong WF
Biomaterials; 2018 Feb; 154():147-157. PubMed ID: 29128843
[TBL] [Abstract][Full Text] [Related]
18. Janus "nano-bullets" for magnetic targeting liver cancer chemotherapy.
Shao D; Li J; Zheng X; Pan Y; Wang Z; Zhang M; Chen QX; Dong WF; Chen L
Biomaterials; 2016 Sep; 100():118-33. PubMed ID: 27258482
[TBL] [Abstract][Full Text] [Related]
19. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.
Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J
Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor efficacy of irinotecan-loaded galactosyl modified lipid bilayer-coated mesoporous silica nanoparticles against hepatocellular carcinoma cells].
Chen X; Zhang XX; Li FF; Zhao YN; Jia Z; Gan Y; Li J
Yao Xue Xue Bao; 2014 May; 49(5):718-25. PubMed ID: 25151746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]